ALICE: A randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
Comparison of diagnostic accuracy for three different image recording devices at the Breast Diagnostic center, Stavanger University Hospital
